$5.66 +0.01 (%) Immunogen Inc - NASDAQ

May. 27, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. ImmunoGen Announces Recent Product Program Advancements and Anticipated 2016 Events in Advance of J.P. Morgan Healthcare Conference

    Benzinga | Jan. 10, 2016 | 18:13PM EST
  2. Mid-Morning Market Update: Markets Edge Higher; Deere Profit Tops Views

    Benzinga | Nov. 25, 2015 | 10:16AM EST
  3. Response to ImmunoGen's Mirvetuximab Soravtansine Found to be Substantially Greater in Ovarian Cancer with High Expression of Folate Receptor Alpha

    Benzinga | Nov. 8, 2015 | 16:56PM EST
  4. Benzinga's Top Downgrades

    Benzinga | Sep. 22, 2015 | 09:45AM EST
  5. Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views

    Benzinga | Sep. 21, 2015 | 10:29AM EST
  6. Morning Market Losers

    Benzinga | Sep. 21, 2015 | 09:52AM EST
  7. Benzinga's Top Downgrades

    Benzinga | Sep. 21, 2015 | 09:41AM EST
  8. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 21, 2015 | 08:21AM EST
  9. Stocks Easing Off Day's Lows; Caesarstone Rebounds

    IBD | Aug. 7, 2015 | 13:00PM EST
  10. Stocks Start Little Changed; CDW Jumps On Earnings

    IBD | Aug. 3, 2015 | 10:28AM EST
  11. Benzinga's Top Downgrades

    Benzinga | Aug. 3, 2015 | 09:25AM EST
  12. Stocks Stay Near Session Highs; ImmunoGen Surges

    IBD | Jul. 16, 2015 | 14:52PM EST
  13. Stocks Hold Near Day's High; Amazon, Immunogen Break Out

    IBD | Jul. 13, 2015 | 13:25PM EST
  14. ASCO Moves Pharma Shares

    IBD | Jun. 1, 2015 | 18:52PM EST
  15. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD | Jun. 1, 2015 | 17:48PM EST
  16. 4 Stocks Rising On ASCO Cancer Drug News

    IBD | Jun. 1, 2015 | 12:34PM EST
  17. ImmunoGen Shares Looking Healthy After Favorable IMGN853 Report

    Benzinga | Jun. 1, 2015 | 11:52AM EST
  18. Benzinga's Volume Movers

    Benzinga | Jun. 1, 2015 | 10:58AM EST
  19. Morning Market Gainers

    Benzinga | Jun. 1, 2015 | 10:16AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 1, 2015 | 08:08AM EST
  21. Here's Why Oppenheimer Upgraded ImmunoGen To Outperform

    Benzinga | Feb. 6, 2015 | 10:45AM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 2, 2015 | 08:23AM EST
  23. Gulf Resources (GURE) Soars on Natural Gas Discovery, ImmunoGen (IMGN) and Synaptics (SYNA) ...

    GuruFocus | Jan. 31, 2015 | 20:55PM EST
  24. ImmunoGen Shares Surge 30% Following Earnings

    Benzinga | Jan. 30, 2015 | 14:16PM EST
  25. Earnings Scheduled For January 30, 2015

    Benzinga | Jan. 30, 2015 | 04:57AM EST
  26. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  27. Roche Halts Alzheimer's Trial

    IBD | Dec. 19, 2014 | 18:47PM EST
  28. Mid-Day Losers From December 19: ImmunoGen, NQ Mobile And More

    Benzinga | Dec. 19, 2014 | 13:33PM EST
  29. Juno Therapeutics IPO Caps Big Year In Biotech Deals

    IBD | Dec. 19, 2014 | 12:47PM EST
  30. Top 3 Short Ideas Among Friday's Losers

    Benzinga | Dec. 19, 2014 | 12:21PM EST
  31. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD | Dec. 19, 2014 | 11:31AM EST
  32. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 19, 2014 | 09:33AM EST
  33. #PreMarket Movers From December 19, 2014: NQ Mobile, BlackBerry, CarMax And More

    Benzinga | Dec. 19, 2014 | 09:20AM EST
  34. Will ImmunoGen's Q4 Earnings Disappoint Again?

    GuruFocus | Jul. 30, 2014 | 19:21PM EST
  35. Wednesday's Biggest Movers

    Benzinga | Jun. 25, 2014 | 16:49PM EST
  36. Shares Of ImmunoGen Down On Morgan Stanley's Bearish Initiation

    Benzinga | Jun. 25, 2014 | 08:26AM EST
  37. Benzinga's Top Initiations

    Benzinga | Jun. 25, 2014 | 08:21AM EST
  38. UPDATE: Canaccord Genuity Initiates Coverage on ImmunoGen Ahead of Phase 3 Data

    Benzinga | Apr. 16, 2014 | 09:29AM EST
  39. ImmunoGen Says Initial Research Shows New Dosing Approach for IMGN853 Achieves Objective

    Benzinga | Apr. 8, 2014 | 16:17PM EST
  40. IDEXX Laboratories Elects Daniel Junius to Board of Directors

    Benzinga | Mar. 11, 2014 | 16:24PM EST
  41. US Stock Futures Down Ahead Of Wal-Mart Earnings, Economic Data

    Benzinga | Feb. 20, 2014 | 07:05AM EST
  42. CytomX Therapeutics, ImmunoGen Announce Strategic Collaboration

    Benzinga | Jan. 9, 2014 | 06:39AM EST
  43. ImmunoGen Announces Activity Reported with SAR3419 Plus Rituxan In Difficult-to-Treat Patient Population at ASH

    Benzinga | Dec. 9, 2013 | 11:31AM EST
  44. US Stock Futures Edge Lower Ahead Of FOMC Minutes, Economic Data

    Benzinga | Nov. 20, 2013 | 07:00AM EST
  45. ImmunoGen Announces Approval of Roche's Kadcyla in EU

    Benzinga | Nov. 20, 2013 | 05:56AM EST
  46. UPDATE: Morgan Stanley Downgrades ImmunoGen Following Phase 2 Failure of IMGN901

    Benzinga | Nov. 11, 2013 | 10:00AM EST
  47. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 11, 2013 | 08:19AM EST
  48. ImmunoGen Announces License Agreement with Novartis

    Benzinga | Nov. 11, 2013 | 06:38AM EST
  49. Mid-Afternoon Market Update: Marvell Rises on KKR Stake While Orbitz Gives Up Last Week's Gains

    Benzinga | Nov. 5, 2013 | 15:23PM EST
  50. Mid-Day Market Update: BroadSoft Drops On Q3 Results; Endo Health Shares Spike Higher

    Benzinga | Nov. 5, 2013 | 12:29PM EST
Trading Center